(1) Boston IVF, Waltham, MA, USA;(2) Sioux Biochemical, Inc., Sioux Center, IA, USA;(3) EMD Serono, Inc. (an affiliate of Merck KGaA, Darmstadt, Germany), Rockland, MA, USA
Abstract:
Background
The current study was designed to determine if follitropin alfa (recombinant human follicle-stimulating hormone; r-hFSH) and
lutropin alfa (recombinant human luteinizing hormone; r-hLH) biopotencies were unchanged by reconstituting in sterile water
for injection and mixing prior to injection.